Notes - Segment Information, Etc.

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7601173

Concept 2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
Notes - Segment information, etc.
Segment information
Disclosure of sales, profit (loss), asset, liability, and other items for each reportable segment
Sales
Revenues from external customers
5,816,000,000 JPY
50,791,000,000 JPY
56,607,000,000 JPY
JPY
56,607,000,000 JPY
Transactions with other segments
73,000,000 JPY
JPY
73,000,000 JPY
-73,000,000 JPY
JPY
Other items
Depreciation
5,000,000 JPY
2,546,000,000 JPY
2,551,000,000 JPY
136,000,000 JPY
2,687,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.